National Academy of Medicine
National Academy of Medicine is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at National Academy of Medicine.
National Academy of Medicine is a company.
Key people at National Academy of Medicine.
Key people at National Academy of Medicine.
The National Academy of Medicine (NAM) is not a company; it is a private, nonprofit, independent national academy and evidence‑based advisor on health and medicine that operates within the National Academies of Sciences, Engineering, and Medicine[2][4].
High‑Level Overview
The National Academy of Medicine (NAM) is an independent, nonprofit institution that produces nonpartisan, evidence‑based analyses, reports, and initiatives to improve health policy, health systems, and population health both in the U.S. and globally[3][4]. Founded as the Institute of Medicine in 1970 and reconstituted as NAM in 2015, it convenes volunteer expert committees, issues authoritative reports, and runs action collaboratives, leadership programs, and public‑private initiatives to translate science into policy and practice[2][3]. The NAM’s mission is to advance science, accelerate health equity, and provide independent, trusted advice to improve health for all[1][4].
Origin Story
The organization was established in 1970 under the congressional charter of the National Academy of Sciences as the Institute of Medicine (IOM)[2][4]. In 2015 the membership and program activities of the IOM were reconstituted as the National Academy of Medicine within the National Academies structure, creating a dedicated division on health and medicine[2]. NAM’s work is carried out primarily through volunteer committees of leading scientists and practitioners who are selected and vetted to avoid conflicts of interest and whose reports undergo extensive external peer review[2][8].
Core Differentiators
Role in the Broader Tech and Health Landscape
Quick Take & Future Outlook
NAM will likely continue to be a central, credible convenor and advisor as pressures on health systems grow and as new technologies (digital health, AI/ML, genomics) intersect with policy and equity issues[3][5]. Key trends that will shape NAM’s role include health equity and social determinants of health, readiness for biological threats, governance of AI in medicine, and integration of systems‑level solutions; NAM’s combination of academy membership, committee reports, and implementation‑focused collaboratives positions it to both diagnose problems and help coordinate multisector responses[3][4]. For stakeholders, the practical question is how NAM’s consensus recommendations will be operationalized by governments, funders, and private actors to produce measurable change—and NAM’s emphasis on action collaboratives and leadership development suggests an increasing focus on implementation capacity, not just analysis[3][4].
If you’d like, I can (a) pull a short list of NAM recent influential reports or action collaboratives relevant to a specific technology or policy area (for example, AI in health or pandemic preparedness), or (b) outline how NAM’s reports have previously affected regulation and investment decisions.
